Aull & Monroe Investment Management Corp continued to hold its stake in CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,580 shares of the financial services provider’s stock at the close of the second quarter. Aull & Monroe Investment Management Corp’s holdings in CME Group were worth $1,576,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Fiduciary Trust Co. bought a new position in CME Group during the 2nd quarter worth $105,000. Parallel Advisors LLC raised its position in CME Group by 4.1% during the 1st quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock worth $128,000 after purchasing an additional 43 shares during the last quarter. Whittier Trust Co. raised its position in CME Group by 2.6% during the 2nd quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock worth $133,000 after purchasing an additional 27 shares during the last quarter. RidgeWorth Capital Management LLC raised its position in CME Group by 55.5% during the 1st quarter. RidgeWorth Capital Management LLC now owns 1,138 shares of the financial services provider’s stock worth $135,000 after purchasing an additional 406 shares during the last quarter. Finally, Mckinley Capital Management LLC Delaware bought a new position in CME Group during the 2nd quarter worth $150,000. Institutional investors own 82.64% of the company’s stock.

CME has been the subject of several analyst reports. UBS AG reaffirmed a “buy” rating and set a $134.00 target price (down from $136.00) on shares of CME Group in a research report on Monday, June 5th. Royal Bank Of Canada set a $130.00 target price on CME Group and gave the stock a “buy” rating in a research report on Monday, June 12th. BidaskClub raised CME Group from a “sell” rating to a “hold” rating in a research report on Friday, June 23rd. Deutsche Bank AG lowered their target price on CME Group from $139.00 to $136.00 and set a “buy” rating for the company in a research report on Tuesday, July 4th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $128.00 target price on shares of CME Group in a research report on Monday, July 10th. One analyst has rated the stock with a sell rating, two have issued a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $133.22.

CME Group Inc. (CME) traded down 0.14% on Thursday, hitting $134.34. The stock had a trading volume of 171,925 shares. The company has a market cap of $45.66 billion, a P/E ratio of 27.42 and a beta of 0.72. The stock’s 50-day moving average is $126.73 and its 200-day moving average is $122.14. CME Group Inc. has a 52-week low of $98.95 and a 52-week high of $134.99.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The company had revenue of $925.00 million during the quarter, compared to the consensus estimate of $931.05 million. During the same period in the prior year, the firm earned $1.14 earnings per share. CME Group’s revenue was up 2.1% on a year-over-year basis. Analysts expect that CME Group Inc. will post $4.82 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Monday, September 25th. Investors of record on Friday, September 8th were paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date was Thursday, September 7th. CME Group’s payout ratio is currently 53.99%.

WARNING: “Aull & Monroe Investment Management Corp Has $1,576,000 Stake in CME Group Inc. (CME)” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/28/aull-monroe-investment-management-corp-has-1576000-stake-in-cme-group-inc-cme.html.

In other CME Group news, insider Hilda Harris Piell sold 714 shares of the firm’s stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $129.00, for a total transaction of $92,106.00. Following the completion of the transaction, the insider now owns 28,844 shares of the company’s stock, valued at $3,720,876. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Dennis Suskind sold 750 shares of the firm’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $129.34, for a total transaction of $97,005.00. Following the transaction, the director now directly owns 5,059 shares of the company’s stock, valued at approximately $654,331.06. The disclosure for this sale can be found here. Over the last three months, insiders sold 48,244 shares of company stock valued at $6,021,890. 0.57% of the stock is owned by insiders.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.